| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 19477320
[patent_doc_number] => 20240325362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => NOVEL THERAPEUTIC METHOD FOR ENHANCING MITOCHONDRIAL FUNCTION, TREATING MITOCHONDRIAL DISEASES THEREBY, AND COMPOUNDS USED THEREIN
[patent_app_type] => utility
[patent_app_number] => 18/262721
[patent_app_country] => US
[patent_app_date] => 2021-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262721
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262721 | NOVEL THERAPEUTIC METHOD FOR ENHANCING MITOCHONDRIAL FUNCTION, TREATING MITOCHONDRIAL DISEASES THEREBY, AND COMPOUNDS USED THEREIN | Jul 15, 2021 | Abandoned |
Array
(
[id] => 18610830
[patent_doc_number] => 20230277560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CHRNA4 MUTATION
[patent_app_type] => utility
[patent_app_number] => 18/005868
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005868
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005868 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CHRNA4 MUTATION | Jul 14, 2021 | Pending |
Array
(
[id] => 18626627
[patent_doc_number] => 20230285424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
[patent_app_type] => utility
[patent_app_number] => 18/005852
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005852
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005852 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Jul 14, 2021 | Pending |
Array
(
[id] => 18610831
[patent_doc_number] => 20230277561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
[patent_app_type] => utility
[patent_app_number] => 18/005959
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005959
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005959 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Jul 14, 2021 | Abandoned |
Array
(
[id] => 18626622
[patent_doc_number] => 20230285419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
[patent_app_type] => utility
[patent_app_number] => 18/005841
[patent_app_country] => US
[patent_app_date] => 2021-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005841
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005841 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | Jul 14, 2021 | Abandoned |
Array
(
[id] => 18595974
[patent_doc_number] => 20230270764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITION COMPRISING CANNABINOIDS, TERPENES, AND FLAVONOIDS FOR TREATING DEPRESSION
[patent_app_type] => utility
[patent_app_number] => 18/015790
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015790
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015790 | COMPOSITION COMPRISING CANNABINOIDS, TERPENES, AND FLAVONOIDS FOR TREATING DEPRESSION | Jul 13, 2021 | Pending |
Array
(
[id] => 19563491
[patent_doc_number] => 12138241
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Compositions for preventing and treating diabetes
[patent_app_type] => utility
[patent_app_number] => 17/305510
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 9527
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17305510
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/305510 | Compositions for preventing and treating diabetes | Jul 7, 2021 | Issued |
Array
(
[id] => 19157575
[patent_doc_number] => 20240150282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => NOVEL CRYSTALLINE COMPOUND OF SIPONIMOD HEMIFUMARATE
[patent_app_type] => utility
[patent_app_number] => 18/273813
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273813
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273813 | NOVEL CRYSTALLINE COMPOUND OF SIPONIMOD HEMIFUMARATE | Jul 6, 2021 | Abandoned |
Array
(
[id] => 20329626
[patent_doc_number] => 12459891
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => 1-[1-(4-benzyloxy-3,5-difluoro-benzoyl)-4-fluoro-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile
[patent_app_type] => utility
[patent_app_number] => 18/004658
[patent_app_country] => US
[patent_app_date] => 2021-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9531
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004658
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004658 | 1-[1-(4-benzyloxy-3,5-difluoro-benzoyl)-4-fluoro-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile | Jul 5, 2021 | Issued |
Array
(
[id] => 18091215
[patent_doc_number] => 20220409556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => COMPOSITION AND METHOD FOR TREATING AUTISM SPECTRUM DISORDER (ASD) SYMPTOMS OF PARANOIA WITH SELF ISOLATION AND/OR AGGRESSION
[patent_app_type] => utility
[patent_app_number] => 17/359272
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359272
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359272 | Composition and method for treating autism spectrum disorder (ASD) symptoms of paranoia with self isolation and/or aggression | Jun 24, 2021 | Issued |
Array
(
[id] => 18496038
[patent_doc_number] => 20230218570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => Methods and Compositions for Treating Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder
[patent_app_type] => utility
[patent_app_number] => 18/009161
[patent_app_country] => US
[patent_app_date] => 2021-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009161
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009161 | Methods and Compositions for Treating Mild Traumatic Brain Injury, Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury with Post Traumatic Stress Disorder | Jun 14, 2021 | Abandoned |
Array
(
[id] => 18091232
[patent_doc_number] => 20220409573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Hippocampus Regeneration And Memory Recovery
[patent_app_type] => utility
[patent_app_number] => 17/345275
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14793
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345275
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345275 | Hippocampus Regeneration And Memory Recovery | Jun 10, 2021 | Abandoned |
Array
(
[id] => 20802675
[patent_doc_number] => 12667563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-06-30
[patent_title] => Prophylactic or therapeutic agent for porphyria
[patent_app_type] => utility
[patent_app_number] => 18/009107
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1886
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009107
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009107 | Prophylactic or therapeutic agent for porphyria | Jun 9, 2021 | Issued |
Array
(
[id] => 18451311
[patent_doc_number] => 20230192588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/000224
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12146
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000224
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000224 | CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF | Jun 2, 2021 | Pending |
Array
(
[id] => 17312795
[patent_doc_number] => 20210401843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA
[patent_app_type] => utility
[patent_app_number] => 17/337097
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337097
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337097 | Methods for killing antibiotic tolerant bacteria | Jun 1, 2021 | Issued |
Array
(
[id] => 17227091
[patent_doc_number] => 20210353647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING ACNE VULGARIS
[patent_app_type] => utility
[patent_app_number] => 17/327559
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327559 | Compositions and methods for treating acne vulgaris | May 20, 2021 | Issued |
Array
(
[id] => 17227075
[patent_doc_number] => 20210353631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => 1,4-Benzoxazines for the Treatment of Cancers and Other Neurodegenerative Diseases
[patent_app_type] => utility
[patent_app_number] => 17/317980
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317980 | 1,4-Benzoxazines for the Treatment of Cancers and Other Neurodegenerative Diseases | May 11, 2021 | Abandoned |
Array
(
[id] => 20912780
[patent_doc_number] => 12709620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-08-18
[patent_title] => Compound for adjusting activity of NMDA receptor, and pharmaceutical composition and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/998626
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25535
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 306
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17998626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/998626 | COMPOUND FOR ADJUSTING ACTIVITY OF NMDA RECEPTOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | May 11, 2021 | Pending |
Array
(
[id] => 17227009
[patent_doc_number] => 20210353565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => ANTIFUNGAL PROPHYLAXIS FOR CORNEA
[patent_app_type] => utility
[patent_app_number] => 17/318048
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27348
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318048
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318048 | Antifungal prophylaxis for cornea | May 11, 2021 | Issued |
Array
(
[id] => 17227066
[patent_doc_number] => 20210353622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => METHODS FOR TREATING HAIR LOSS AND COMPOSITIONS FOR SAME
[patent_app_type] => utility
[patent_app_number] => 17/302781
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3731
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/302781 | METHODS FOR TREATING HAIR LOSS AND COMPOSITIONS FOR SAME | May 11, 2021 | Pending |